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predictive variables for ureteral stone impaction and to ana-
lyse the effect of impaction on outcomes.
Results Of the 8543 treated patients, 2650 (31%) had 
impacted and 5893 (69%) non-impacted stones. The stone-
free rate was 87.1% for impacted stones, which is lower 
compared with 92.7% for non-impacted stones (p < 0.001). 
Intra-operative complication rates were higher for impacted 
stones (7.9 versus 3.0%, p < 0.001). Significantly higher 
ureteral perforation- and avulsion rates were reported in 
the impacted stone group compared with the non-impacted 
stone group. No association between stone impaction and 
post-operative complications could be shown. Female 
gender, ASA-score >1, prior stone treatment, positive pre-
operative urine culture, and larger stones showed to be pre-
dictive variables for stone impaction.
Conclusions Ureteroscopic treatment for impacted stones 
is associated with lower stone-free rates and higher intra-
operative complication rates compared with treatment for 
non-impacted stones. The predictive variables for the pres-
ence of stone impaction may contribute to the identification 
of stone impaction during the diagnostic process. Moreo-
ver, identification of stone impaction may aid the selection 
of the optimal treatment modality.
Keywords Urolithiasis · Impacted stones · Ureter · 
Ureteroscopy · Treatment outcomes · Complications
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Abstract 
Purpose To describe stone-free rates and complications 
of ureteroscopic treatment for impacted compared with 
non-impacted ureteral stones and evaluate predictive vari-
ables for impaction.
Methods The Clinical Research Office of the Endouro-
logical Society prospectively collected 1 consecutive year 
of data from 114 centers worldwide. Patients eligible for 
inclusion were patients treated with ureteroscopy for ure-
teral stones. Patient characteristics, treatment details, and 
outcomes were compared with regard to stone impaction. 
Logistic regression analyses were conducted to explore 
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Introduction
Impacted ureteral stones are stones that remain unchanged 
at the same location for a prolonged time period causing 
local inflammation [1]. Confirmation of ureteral stone 
impaction can be done during ureteroscopy, displaying 
a stone enveloped in a, frequently, inflamed oedematous 
mucosa. The impeded stone exposure and lack of expan-
sion space around the stone make disintegration more dif-
ficult. Patients with impacted ureteral stones are consid-
ered to be at risk for a less effective initial treatment and 
a higher complication rate if compared with patients with 
non-impacted stones [2].
For the treatment of distal and mid-ureteral stones, 
ureteroscopy is the approach of choice. For proximal ure-
ter stones <10  mm, both ureteroscopy and shock wave 
lithotripsy (SWL) are appropriate options. Although SWL 
is a non-invasive modality, it is unlikely to be successful 
for impacted stones. For the treatment of large proximal 
stones, percutaneous lithotomy is an alternative, whereas 
laparoscopic or open lithotomy may be a rarely necessary 
option [3–5].
Daily practice and the literature show that the preva-
lence of impacted ureteral stones is high [2]. Last decades 
research on ureteral stone treatment has been extensive. 
However, the literature focused on the outcomes of uretero-
lithotripsy for impacted ureteral stones is limited. Further-
more, stone impaction is a neglected topic in preeminent 
guidelines.
The aim of this study is to compare the stone-free rate 
(SFR) and complication rates of ureteroscopic lithotripsy 
between patients with and without impacted ureteral stones 
and evaluate predictive variables for impaction.
Patients and methods
Primary objective
To assess the differences in SFR and intra- and short-term 
post-operative complication rates between patients treated 
for impacted stones compared with patients treated for non-
impacted stones.
Secondary objective
To explore variables that predict ureteral stone impaction.
Study organization and data collection
This study examining impacted stones is a sub-analysis 
of the CROES URS Global Study which is a prospective, 
observational, international multicenter study. The CROES 
URS started between January 2010 and October 2011, col-
lecting data on consecutive patients treated with ureter-
oscopy for urolithiasis at each participating center over a 
1-year period.
114 Centers participated in 32 countries and a total of 
11.885 patients were included. Data were collected and 
stored in the online available CROES data management 
system (http://www.croesoffice.org). Participating cent-
ers treated patients according to their local protocols. 
More detailed data containing the global URS study are 
described elsewhere [6].
Study population
Patients eligible for inclusion were all patients treated with 
ureteroscopy for ureteral stones, as a primary or secondary 
treatment. Patients with ureteral stones in combination with 
renal stones were excluded to preclude possible influence 
on outcomes of renal stone treatment in the same session. 
Patients were divided into an impacted and a non-impacted 
stone group. Impaction had to be verified endoscopically 
[1, 2]. Whether a stone was impacted or not was deter-
mined by the surgeon and answered with the option yes 
or no. If stone impaction information was absent, patients 
were excluded from analysis.
Patients characteristics
Patients baseline characteristics include age in years, gen-
der, ASA-score (American Society of Anaesthesiologists 
score), BMI, medical history, prior stone treatment, and 
anticoagulant use. Stone characteristics are captured in 
stone width and length in mm and measured on the imag-
ing modality that was used for pre-operative evaluation. 
Stone burden was calculated using the formula: length × wi
dth × 0.25 × 3.14159.
Intra-operative characteristics are operation time in min-
utes, intra-operative complications, and stone-free status.
Patient follow‑up and secondary treatment
Imaging consisted of x-ray and ultrasound of kidneys, ure-
ter, and bladder, or computed tomography scan of the abdo-
men. Classification of a stone-free status was attained by 
the overall absence of stones or fragments larger than 1 mm 
based on imaging techniques available, and left to the dis-
cretion of the treating physician.
Post-operative characteristics, used as study outcomes, 
are long hospital stay (defined as longer versus shorter than 
1  day), re-admission (any possible procedure related hos-
pital visit, including re-treatment), and post-operative com-
plications according to the Clavien–Dindo Grading system 
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[7]. The follow-up period for the registration of post-opera-
tive complications was 3 months.
Statistical analysis
Descriptive information is presented as mean with the 
standard deviation for continuous normally distributed var-
iables, and median with inter-quartile ranges for continuous 
skewed variables. Categorical variables are presented as 
percentages. Descriptive data and percentages were based 
on available data. To compare outcomes between groups, 
Pearson’s Chi-square or Fisher’s exact test was used for 
dichotomous and categorical variables. A Student’s t test 
was used for continuous normally distributed variables and 
a Mann–Whitney U test for skewed variables.
Logistic regression analyses were used to determine 
which variables could predict stone impaction and to evalu-
ate the association between stone impaction and outcomes 
after ureterolithotripsy.
Outcomes tested were SFR and intra-and post-oper-
ative complications. Outcomes were adjusted for possi-
ble confounders, including gender, ASA-score, positive 
pre-operative urine culture, prior stone treatment, stone 
burden, ureteroscopy type, difference in fragmentation 
device, operation time, pre-operative stent placement, and 
post-operative ureteral stent placement, and for differences 
in evaluation modalities uses to determine the absence of 
residual fragments.
For all analysis, the level of statistical significance was 
set at p < 0.05. Statistical analyses were performed using 
IBM SPSS statistics version 23.0.
Results
Patient characteristics
Of 11,885 patients in the URS CROES database, 8630 
patients were treated for ureter stones only. Information 
on stone impaction was missing for 87 patients, remain-
ing 8543 patients for analysis. 2650 (31.0%) Patients were 
treated for impacted stones and 5893 (69.0%) for non-
impacted stones.
Table 1 presents baseline characteristics in patients with 
and without impacted stones. Patients with impacted stones 
had higher ASA II and III scores more often, higher rates 
of cardio vascular disease, higher rates of prior SWL treat-
ment (20.9 versus 14.7%), and a higher stone burden. In 
the 6 months before, the surgery SWL in the ureteral renal 
unit was performed in 12.6% in the impacted stone group 
and 6.9% in the non-impacted stone group (p < 0.001). A 
prior ureteroscopy within 6 months before the current 
ureterolithotripsy was performed in 2.9% in the impacted 
stone group and 3.5% in the non-impacted stone group 
(p = 0.15).
A pre-operative ureteral stent was less often placed (13.7 
versus 15.8%, p = 0.013) in patients with impacted stones, 
whereas a pre-operative percutaneous drain was placed in 
5.5% in the impacted stone group and in 2.8% in the non-
impacted stone group (p < 0.001).
Operative characteristics
The operative characteristics, presented in Table  2, show 
notable higher median operation time, more frequent use 
of laser fragmentation, and post-operative stents in patients 
with impacted stones.
Stone‑free rate
The overall SFR was 87.1% for impacted ureteral stones, 
which is significantly lower compared with 92.7% for non-
impacted stones (Table 2). For both groups, SFRs declined 
with an increase in stone burden (Fig.  1 supplementary 
material).
For the distal and proximal locations, SFR were lower 
with a larger burden. For the mid-ureter, SFRs were higher 
than 80%, even with an increased stone burden (Fig. 2 sup-
plementary material). Stones migrated in 14.4% of the 
impacted stone group and in 7.9% of the non-impacted 
stone group. SFR for procedures were migration occurred 
were 52.4% for impacted stones and 86.6% for non-
impacted stones.
A sub-analysis was performed to show the difference 
between outcomes after semi-rigid and flexible ureteros-
copy for impacted stones in the proximal ureter. An ureteral 
access sheath was used in 61.7% of the flexible ureteros-
copy cases. The SFR was 88.2% for flexible ureteroscopy 
and 76.4% for semi-rigid ureteroscopy, though the average 
stone burden was lower in the flexible ureteroscopy group. 
More specified results with respect to semi-rigid versus 
flexible ureteroscopy can be found in Table  1 in the sup-
plementary material.
Complications
Descriptive information on intra- and post-operative com-
plications is shown in Table 3. The overall intra-operative 
complication rate was higher in patients with impacted 
stones. More specifically, there was a significant differ-
ence in bleeding, ureteral perforations and avulsions, unfa-
vourable to the impacted stone group. Although there was 
a significantly higher overall post-operative complication 
rate in patients who had impacted stones, there were no 
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Table 1  Baseline characteristics
Characteristics All patients
n = 8543
Impacted stones
n = 2650 (31.0)
Non-impacted stones
n = 5893 (69.0)
Difference p value Type of test
Age, mean in years (SD) 47.9 (15.9)
(n = 7328)
49.8 (15.4)
(n = 2412)
47.0 (16.1)
(n = 4916)
<0.001 C
Gender
 Male n (%) 5660 (66.3) 1867 (63.7) 3973 (67.5) 0.001 A
 Female n (%) 2875 (33.7)
(n = 8535)
962 (36.3)
(n = 2649)
1913 (32.5)
(n = 5886)
 BMI mean (SD) 26.6 (4.6)
(n = 7147)
26.9 (4.9)
(n = 2392)
26.4 (4.5)
(n = 4753)
<0.001 C
ASA-score n (%)
 I 4795 (59.3) 1254 (49.4) 3514 (63.9) <0.001 A
 II 2670 (33.0) 982 (38.6) 1688 (30.5)
 III 587 (7.3) 288 (11.3) 299 (5.4)
 IV 31 (0.4)
(n = 8083)
17 (0.7)
(n = 2541)
14 (0.3)
(n = 5542)
Comorbidity and medication n (%)
 DM 840 (9.9)
(n = 8485)
306 (11.6)
(n = 2634)
534 (9.1)
(n = 5851)
<0.001 A
 CVD 2364 (27.7)
(n = 8543)
910 (34.3)
(n = 2650)
1454 (24.7)
(n = 5893)
<0.001 A
 Crohn’s disease 31 (0.4)
(n = 8476)
11 (0.4)
(n = 2632)
20 (0.3)
(n = 5844)
0.59 A
 Prednisone 58 (0.7)
(n = 8479)
23 (0.9)
(n = 2635)
35 (0.6)
(n = 5844)
0.16 A
 Anticoagulation 393 (4.6)
(n = 8481)
166 (6.3)
(n = 2633)
227 (3.9)
(n = 5848)
<0.001 A
Previous stone treatment n (%)
 URS 880 (10.4)
(n = 8491)
269 (10.2)
(n = 2635)
611 (10.4)
(n = 5856)
0.75 A
 PCNL 264 (3.1)
(n = 8494)
81 (3.1)
(n = 2636)
183 (3.1)
(n = 5858)
0.090 A
 SWL 1407 (16.6)
(n = 8471)
548 (20.9)
(n = 2622)
859 (14.7)
(n = 5849)
<0.001 A
 Ureterolithotomy 90 (1.1)
(n = 8492)
49 (1.9)
(n = 2635)
41 (0.7)
(n = 5857)
<0.001 A
 Pyelolithomy 94 (1.1)
(n = 8500)
37 (1.4)
(n = 2639)
57 (1.0)
(n = 5861)
0.080 A
 Pre-operative positive urine culture n (%) 488 (5.9)
(n = 8264)
214 (8.3)
(n = 2569)
274 (4.8)
(n = 5695)
<0.001 A
 Total stone burden  (mm2) median, [IQR] 53.4, [28–85]
(n = 8539)
58.9, [33–95]
(n = 2650)
50.3, [27–79]
(n = 5889)
<0.001 D
Stone location ureter n (%)
 Proximal ureter 2336 (27.3) 772 (29.1) 1564 (26.5) <0.001 A
 Mid-ureter 1784 (20.9) 601 (22.7) 1183 (20.1)
 Distal ureter 4140 (48.5) 1172 (44.2) 2968 (50.4)
 Multiple locations 283 (3.3)
(n = 8543)
105 (4.0)
(n = 2650)
178 (3.0)
(n = 5893)
 Ureteral stent n (%) 1285 (15.1)
(n = 8496)
361 (13.7)
(n = 2637)
924 (15.8)
(n = 5859)
0.013 A
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ASA American Society of Anesthesiologists, DM Diabetes Mellitus, CVD Cardio Vascular Disease, PCNL Percutaneous Nephrolithotomy, 
ESWL Extra Corporeal Shockwave Lithotripsy, URS Ureterorenoscopy, UPJ uretero-pelvic junction
NS not significant. Data are n (%) of patients for whom data were available. Percentages exclude missing values from denominators. Statistical 
test: A Pearson’s Chi-square test, B Fishers exact test, C Student’s t test, D Mann–Whitney U test
Table 1  (continued)
Characteristics All patients
n = 8543
Impacted stones
n = 2650 (31.0)
Non-impacted stones
n = 5893 (69.0)
Difference p value Type of test
 Percutaneous drain n (%) 309 (3.6)
(n = 8498)
144 (5.5)
(n = 2637)
165 (2.8)
(n = 5861)
<0.001 A
Table 2  Operation data comparing impacted stones with non-impacted stones
Data are n (%) of patients for whom data were available. Percentages exclude missing values from denominators. IVU intravenous urography, 
KUB kidneys, ureters, bladder. Statistical test: A Pearson’s Chi-square test, B Fishers exact test, C Student’s t test, D Mann–Whitney U test
Outcomes Impacted stones Non-impacted stones Difference p value Type of test
Overall stone-free rate (SFR) n (%) 2293 (87.1)
(n = 2634)
5423 (92.7)
(n = 5850)
<0.001 A
Proximal ureter SFR n (%) 605 (79.3)
(n = 763)
1364 (88.3)
(n = 1544)
<0.001 A
Mid-ureter SFR n (%) 520 (86.8)
(n = 599)
1090 (92.8)
(n = 1174)
<0.001 A
Distal ureter SFR n (%) 1089 (93.2)
(n = 1168)
2831 (95.8)
(n = 2956)
0.001 A
Multiple ureteral locations SFR
n (%)
79 (76.0)
(n = 104)
138 (78.4)
(n = 176)
0.66 A
Method of evaluation
 CT 353 (13.5) 437 (7.5) <0.001 A
 Ultrasound 1363 (52.1) 3218 (54.9) 0.017 A
 X-ray/KUB 1509 (57.7) 2835 (48.4) <0.001 A
 IVU 197 (7.5) 135 (2.3) <0.001 A
 Retrograde pyelogram 24 (0.9) 138 (2.4) <0.001 A
 Intra-operative confirmation 480 (18.3) 723 (12.3) <0.001 A
 Other 30 (1.1) 33 (0.6) 0.004 A
 None 132 (5.0)
(n = 2617)
253 (4.3)
(n = 5863)
0.14 A
Type of ureteroscope n (%)
 Semi-rigid 2295 (87.0) 5523 (93.9) <0.001 A
 Flexible 137 (5.2) 179 (3.0)
 Both 207 (7.8)
(n = 2639)
181 (3.1)
(n = 5883)
Type of fragmentation device
 Laser 1392 (52.6) 2055 (35.0) <0.001 A
 Pneumatic 856 (32.4) 2540 (43.3)
 Other 171 (6.5) 150 (2.6)
 No device 227 (8.6)
(n = 2646)
1121 (19.1)
(n = 5866)
 Peroperative antibiotics n (%) 2313(88.0)
(n = 2628)
4739 (80.9)
(n = 5856)
<0.001 A
 Anti-retropulsion device used 411(15.5)
(n = 2644)
824 (14.0)
(n = 5888)
0.062 A
 Operation time minutes, median, [IQR] 40, [30–60]
(n = 2612)
30, [21–60]
(n = 5781)
<0.001 D
 Post-operative ureteral stent n (%) 2333 (88.2)
(n = 2644)
2492 (76.2)
(n = 5893)
<0.001 A
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differences between severity of the post-operative compli-
cations, measured by the Clavien–Dindo grades [7].
During the follow-up period of 3  months, 11(0.4%) 
patients in the impacted stone group and 15 (0.3%) patients 
in the non-impacted stone group were re-admitted because 
of a ureteral stricture (p = 0.21).
Post‑operative outcomes
Data on length of hospital stay, re-treatment rate, and 
re-admission rate are shown in Table  3. Patients in the 
impacted stone group had a longer hospital stay, a higher 
re-treatment rate, and a higher re-admission rate compared 
with the non-impacted stone group.
Multivariable logistic regression analysis
Logistic regression analyses, presented in Table 4, were 
conducted to evaluate the association between stone 
impaction and primary outcomes.
Stone impaction gives an odds ratio of 0.57 on a stone-
free status and an odds ratio of 3.23 on intra-operative 
complications. This suggests that patients with impacted 
stones are less often stone free, but these patients also 
experience more intra-operative complications. No asso-
ciation between ureteral stone impaction and short-term 
post-operative complication rate was found.
Table 3  Intra- and post-
operative complications and 
outcomes
UTI urinary tract infection, NS not significant. Data are n (%) of patients for whom data were available. Per-
centages exclude missing values from denominators. Statistical test: A Pearson’s Chi-square test, B Fishers 
exact test, C Student’s t test, D Mann–Whitney U test
Outcomes Impacted stones
(n = 2650)
Non-impacted stones
(n = 5893)
Difference p value Type of test
Intra-operative complications n (%)
 Overall 209 (7.9) 177 (3.0) <0.001 A
 Bleeding 65 (2.5) 37 (0.6) <0.001 A
 Perforation 59 (2.2) 31 (0.5) <0.001 A
 Failed procedure 55 (2.1) 83 (1.4) 0.023 A
 Conversion 7 (0.3) 5 (0.08) 0.057 B
 Avulsion 9 (0.3) 1 (0.02) <0.001 B
 Other 14 (0.5)
(n = 2643)
20 (0.3)
(n = 5887)
0.20 A
Intra-operative migration n (%) 380 (14.4)
(n = 2643)
463 (7.9)
(n = 5887)
<0.001 A
Post-operative complications n (%)
 Overall 75 (2.8) 106 (1.8) 0.002 A
 Bleeding 15 (0.6) 15 (0.3) 0.53 A
 Fever (>38.0) 23 (0.9) 33 (0.6) 0.10 A
 UTI 20 (0.8) 24 (0.4) 0.038 A
 Sepsis 7 (0.3) 10 (0.2) 1.0 B
Other 10 (0.4)
(n = 2650)
24 (0.4)
(n = 5893)
0.84 A
Clavien grading score n (%)
 I 31 (40.3) 41 (38.3) 0.68 A
 II 33 (42.9) 48 (44.9)
 IIIa-b 10 (13.0) 13 (12.1)
 IVa-b 3 (3.8) 3 (2.8)
 V 0 (0)
(n = 2573)
2 (1.9)
(n = 5786)
Post-operative hospital stay 
longer than 24 h n (%)
1211 (45.8)
(n = 2643)
1757 (29.9)
(n = 5873)
<0.001 A
Re-treatment n (%) 307 (11.6)
(n = 2647)
491 (8.1)
(n = 5886)
<0.001 A
Re-admission <3 months n (%) 241 (9.6)
(n = 2518)
346 (6.2)
(n = 5615)
<0.001 A
1503World J Urol (2017) 35:1497–1506 
1 3
Prediction of impaction
Table 5 shows univariate and multivariate prediction mod-
els of stone impaction. Female gender, ASA-score >1, a 
positive pre-operative urine culture, prior treatment and a 
larger stone burden showed to be predictive variables for 
stone impaction.
Discussion
The main outcome of this study is that the treatment of 
impacted stones with ureterolithotripsy is associated with 
lower SFRs and a higher intra-operative complication 
rate compared with non-impacted stones. No association 
between stone impaction and short-term post-operative 
complications was found. Female gender, ASA-score >1, a 
positive pre-operative urine culture, prior stone treatment, 
and larger stone burdens were found to be predictive vari-
ables for impacted ureteral stones.
Stone‑free rate
In this study, stone impaction was associated with lower 
SFR. Comprehensive work analysing ureteroscopic treat-
ment for impacted stones with the semi-rigid Ho:YAG 
laser was done by Seitz et al. in 2007 [2], and they report 
an overall SFR of 82% with an SFR of 67.2% for stones 
in the proximal ureter. A possible explanation for the fact 
that we found higher SFRs could be the expansion in use of 
flexible ureteroscopy, increased experience, and improved 
techniques in endourological surgery over the past dec-
ade [8]. Another study presented by Binbay et al. showed 
SFRs of 80% using a pneumatic lithotripter and 97.5% for 
the Ho:YAG laser. This high effectiveness can be explained 
by excluding patients with stones >20  mm, using perma-
nent anticoagulants, those with ureteral strictures, multiple 
stones, anatomical abnormalities, renal insufficiency, and 
a previously unsuccessful ureteroscopic procedures [9]. In 
this study, we found a lower SFR for the treatment of larger 
(>80  mm2) impacted stones in the proximal ureter. The 
average SFR for larger stones drops to 71.4%.
Aside from the use of retrograde ureterolithotripsy, 
PCNL is an alternative option for the removal of larger 
proximal ureter stones. Previous studies compared PCNL 
with antegrade ureterolithotripsy for the treatment of larger 
(≥10  mm) impacted proximal ureteral stones. Reported 
SFR for PCNL varied from 96 to 100% which is higher 
than the SFR of 58–89% achieved with retrograde uretero-
lithotripsy [10–13].
Table 4  Examining the effect of ureteral stone impaction on out-
comes corrected for confounders using multivariate logistic regres-
sion
Outcomes Odds ratio 95% 
confidence 
interval
p value
Model 1: Association of stone impaction and outcomes after ureter-
oscopy (univariate analysis)
 Stone-free rate 0.53 0.46–0.62 <0.001
 Intra-operative complications 2.77 2.26–3.40 <0.001
 Post-operative complications 1.59 2.65–5.98 <0.001
Model 2: Association of impaction on outcomes after ureteroscopy 
corrected for baseline characteristics and stone characteristics 
found significant in the prediction model
 Stone-free rate 0.57 0.48–0.67 <0.001
 Intra-operative complications 2.71 2.17–3.38 <0.001
 Post-operative complications 1.43 1.04–1.98 0.030
Model 3 Association of impaction on outcomes after ureteroscopy 
corrected for baseline characteristics and clinically possible 
confounders
 Stone-free rate 0.57 0.48–0.68 <0.001
 Intra-operative complications 3.23 2.54–4.11 <0.001
 Post-operative complications 1.34 0.95–1.90 0.095
Table 5  Logistic regression 
model for predictors of stone 
impaction
NS not significant, ASA 1 score reference category
Predictive variable Univariate Multivariate
Odds ratio 95% confi-
dence interval
p value Odds ratio 95% confi-
dence interval
p value
Female gender 1.18 1.08–1.30 0.001 1.15 1.03–1.27 0.01
ASA-score
 II 1.64 1.48–1.82 <0.001 1.59 1.43–1.77 <0.001
 III 2.72 2.29–3.24 <0.001 2.58 2.14–3.11 <0.001
 IV 3.43 1.69–6.98 0.001 3.58 1.72–7.45 0.001
Pre-operative posi-
tive urine culture
1.87 1.55–2.26 <0.001 1.21 1.14–1.29 <0.001
Total stone burden 1.29 1.23–1.36 <0.001 1.26 1.19–1.33 <0.001
Previous treatment 1.34 1.22–1.48 <0.001 1.23 1.11–1.36 <0.001
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The difference in SFR using ureteroscopy for impacted 
stones compared with non-impacted stones may be 
explained by several factors. The impeded stone exposure 
makes the surgical procedure technically more difficult [2, 
14]. Furthermore, a higher intra-operative complication 
rate, in particular bleeding, can lead to early cessation of 
the procedure resulting in an incomplete stone disintegra-
tion. Moreover, in this study, stone migration also seems to 
influence SFRs. The prevalence of migration for impacted 
stones was much higher with much lower SFRs compared 
to migrated non-impacted stones. It could be that patients 
with impacted stone were more likely to have hydrone-
phrosis or a higher degree of hydronephrosis resulting in a 
higher intra-operative migration rate [15].
Finally, the usage of diverse intracorporeal lithotripter 
devices could be a factor affecting effectiveness of uretero-
lithotripsy for impacted stones. In this study, this was not 
investigated. Previous studies revealed that the use of the 
Ho:YAG laser is more effective than pneumatic lithotripsy 
[9, 16, 17].
Complications
Intra- and post-operative complication rates were found 
to be significantly related to ureteral stone impaction. The 
current study shows a higher intra-operative complication 
rate for impacted stones.
Seitz and colleagues found higher intra- and post-oper-
ative complication rates in patients with impacted stones 
compared to those without impacted stones. Although in 
both the current study and the study by Seitz, complication 
rates are low, the actual number may be different due to dif-
ferences in patient selection and definition of complications 
[2]. Currently reported complication rates for ureteroscopic 
treatment are comparable with complication rates in overall 
populations [14, 18, 19].
Predictors of stone impaction
Predictive variables could help us identify which patients 
have impacted stones, but may also help clarify the pro-
cess of impaction. The process of stone impaction causes 
an inflammatory reaction of the ureteral mucosa with the 
genesis of oedema and fibrosis of the ureteral wall [2, 20].
We did not find literature elucidating our finding that 
female gender predicts impaction. Subsequently, we do not 
assume that there is a causal relation between female gen-
der and impaction.
We found that patients with an ASA-score >1 are more 
often affected. An explanation may be the higher preva-
lence of comorbidity affecting the quality and regenerative 
capacity of ureteral tissue which can result in a higher risk 
of inflammation and fibrosis and thereby impaction.
Another predictor for stone impaction is prior stone 
treatment in the same ureteral–renal unit. We found that 
SWL was more often performed in patients with impacted 
stones. In earlier publications, it has been reported that 
the effect of SWL is reduced in impacted stones [1, 3, 21]. 
Moreover, prior SWL could increase inflammation and 
oedema of the ureteral wall [22]. This inflammatory reac-
tion may contribute in the process of stone impaction. To 
that end, we suggest that if suspicion of impaction, SWL 
treatment should only be provided reluctantly and may 
even be contra-indicated.
We found that a positive pre-operative urine culture is 
a predictor for impaction. Positive urine cultures are well 
known as a consequence of obstructive uropathy due to 
impaction of ureteral stones. Moreover, infection of the uri-
nary tract may aggravate the inflammatory reaction leading 
to further impaction. Whether urinary tract infections are a 
cause or consequence is not elucidated in this study.
Larger stones also show to be impacted more often. This 
is likely because stone with a larger burden have a low like-
lihood of spontaneous passage [3]. They get stuck in the 
ureter thereby causing pressure on the ureteral wall. This 
stone-induced ureteral wall pressure is suggested to induce 
ischemia, which stimulates ureteral oedema and fibrosis 
leading to impaction [1, 2].
The identified predictors for stone impaction may not 
directly be supportive to explicate preventive strategies for 
the reduction of stone impaction prevalence. Even so, out-
comes may support future prevention strategies. Predicting 
characteristics contribute in the estimation which patients 
will be affected and help to determine the most effective 
and safest treatment option. However, other factors, not 
measured in current analyses could have predictive value. 
For example, a recent study by Sarica et  al. showed that 
assessment of the acute phase reactants CRP and ESR val-
ues along with the measurement of ureteral wall thickness 
are predictive parameters for stone impaction [23].
Limitations
A limitation of this study is the relatively short follow-up 
period of 3 months. A known complication after the treat-
ment of impacted stones is the formation of ureteral stric-
tures. In literature, stricture rates vary from 8 to 24% [14, 
24–27]. We assume that the reported short-term stricture 
rate in this study firmly underestimates the long-term stric-
ture rate. Extension of the follow-up is needed to evaluate 
the long-term stricture rate.
Second, we are aware that the subjectivity of defining 
stone impaction is an important limitation in this study. In 
this study, stone impaction was confirmed endoscopically. 
Still, the assessment was made by a large number of clini-
cians using their own interpretation assessing impaction.
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In the literature, the definition of stone impaction is 
still not clarified. Most articles state an impacted stone 
as a stone that remains at the same location for at least 
2  months. Further adduced criteria for impaction are the 
inability to pass the stone with a guidewire and failure to 
visualize contrast beyond the stone [1, 9, 28]. With the lack 
of one global standard, consensus on criteria to define stone 
impaction is suggested to optimize quality of research and 
compare outcomes in the literature.
Conclusions
Ureteroscopic treatment for impacted stones showed 
lower SFR and higher intra-operative complication rates 
compared with ureteroscopic treatment for non-impacted 
stones. The predictive variables for the presence of stone 
impaction may contribute to the identification of stone 
impaction during the diagnostic process which may aid the 
selection of the optimal treatment modality.
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